Blefaritis: Etiologi, Klasifikasi, Diagnosis, dan Tata Laksana
DOI:
https://doi.org/10.55175/cdk.v49i10.304Keywords:
Blefaritis, inflamasi kelopak mata, oftalmologisAbstract
Blefaritis merupakan kondisi oftalmologis yang ditandai dengan inflamasi pada margo kelopak mata. Secara anatomis, blefaritis dibagi menjadi blefaritis anterior dan posterior. Pilihan terapi blefaritis telah mengalami perkembangan dalam beberapa tahun terakhir. Kompres hangat dan membersihkan kelopak mata masih menjadi regimen pengobatan dasar; penggunaan antibiotik, steroid, dan inhibitor calcineurin menunjukkan efikasi yang baik. Suplementasi dan berbagai prosedur intervensi mungkin dapat dipertimbangkan di masa depan.
Blepharitis is an ophthalmological condition characterized by inflammation of the eyelids. Anatomically, blepharitis is divided into anterior and posterior blepharitis. Therapeutic options for blepharitis have evolved in recent years. Warm compresses and eyelid hygiene are still the basic treatment regimen, but the use of antibiotics, steroids, and calcineurin inhibitors has shown good efficacy. Supplementations and various possible intervention procedures may be considered in the future.
Downloads
References
Eberhardt M, Rammohan G. Blepharitis. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan. Available from: https://www.ncbi.nlm.nih.gov/books/NBK459305/
Putnam CM. Diagnosis and management of blepharitis: An optometrist’s perspective. Clin Opt. 2016;8:71-8. doi:10.2147/OPTO.S84795
American Academy of Ophthalmology. Preferred practice pattern: Blepharitis [Internet]. 2012. Available from: http://one.aao.org/preferred-practice-pattern/blepharitis-ppp--2013.
Pflugfelder SC, Karpecki PM, Perez VL. Treatment of blepharitis: Recent clinical trials. Ocul Surf. 2014;12(4):273-84. doi: 10.1016/j.jtos.2014.05.005.
Lemp MA, Nichols KK. Blepharitis in the United States 2009: A survey-based perspective on prevalence and treatment. Ocul Surf. 2009;7(2):1-14
Rim TH, Kang MJ, Choi M, Seo KY, Kim SS. Ten-year incidence and prevalence of clinically diagnosed blepharitis in South Korea: A nationwide population-based cohort study. Clin Exp Opht. 2017;45:448– 54. doi: 10.1111/ceo.12929.
Dias MR, Guaresch BLV, Borges CR, Biazim DF, Casagrande D, Luz RA. Blefarite: Epidemiologia, etiologia, apresentações clínicas, tratamento e evolução de nossos pacientes. Revista Brasileira de Oftalmologia 2019;78(5):300-3.
Putnam CM. Diagnosis and management of blepharitis: An optometrist’s perspective. Clin Optometr. 2016; 8:71-8. doi:10.2147/OPTO.S84795.
Sitorus RS, Sitompul R, Widyawati S, Bani AP. Buku ajar oftalmologi. Jakarta: UI Publishing; 2020.
Din N, Patel NN. Blepharitis – A review of diagnosis and management. Int J Ophthalmol Prac. 2012;3(4):150–5.
Duncan K, Jeng BH. Medical management of blepharitis. Curr Opin Ophthalmol. 2015;26(4):289-94.
Scheinfeld N, Berk T. A review of the diagnosis and treatment of rosacea. Postgrad Med. 2010;122(1):139-43.
Nelson JD, Shimazaki J, Benitez-del-Castillo JM, Craig JP, McCulley JP, Den S, et al. The International Workshop on meibomian gland dysfunction: Report of the definition and classification subcommittee. Invest Ophthalmol Vis Sci. 2011;52(4):1930- 7.
American Academy of Ophthalmology. Blepharitis preferred practice pattern. San Francisco: American Academy of Ophthalmology; 2018
Blepharitis Clinical Practice Guideline. Melbourne: The Royal Victorian Eye and Ear Hospital Emergency Department; 2017
Maskin SL. Intraductal meibomian gland probing relieves symptoms of obstructive meibomian gland dysfunction. Cornea 2010;29:1145–52.
Grenier JV. A single LipiFlow Thermal Pulsation System treatment improves meibomian gland function and reduces dry eye symptoms for 9 months. Curr Eye Res. 2012;37:272-8.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
